PubRank

Kathy K Griendling

Author PubWeight™ 149.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2006 7.84
2 Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003 4.56
3 Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002 3.95
4 Role of oxidative stress in atherosclerosis. Am J Cardiol 2003 3.66
5 Nox proteins in signal transduction. Free Radic Biol Med 2009 3.47
6 Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 2004 3.37
7 Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002 3.32
8 Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007 3.17
9 Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003 3.15
10 Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2006 3.13
11 The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003 3.13
12 Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 2005 3.12
13 Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 2002 3.10
14 Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 2011 3.08
15 Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 2012 3.02
16 Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 2009 2.83
17 NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2009 2.83
18 Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 2008 2.68
19 Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res 2004 2.48
20 Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006 2.24
21 NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 2008 2.22
22 Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 2002 2.18
23 Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem 2003 2.09
24 Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 2005 2.05
25 Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 2009 2.01
26 Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 2006 1.89
27 Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 2007 1.81
28 Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res 2004 1.77
29 Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2003 1.73
30 NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 2002 1.64
31 Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol 2007 1.57
32 Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 2004 1.57
33 Reactive oxygen species in hypertension; An update. Am J Hypertens 2004 1.56
34 Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic Biol Med 2011 1.56
35 Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 2008 1.52
36 Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension 2005 1.49
37 Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II. Arterioscler Thromb Vasc Biol 2007 1.47
38 NADPH oxidase inhibitors: new antihypertensive agents? J Cardiovasc Pharmacol 2007 1.44
39 Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem 2008 1.43
40 RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 2006 1.41
41 Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med 2005 1.36
42 Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med 2004 1.34
43 Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol 2010 1.31
44 Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol 2004 1.29
45 Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radic Biol Med 2008 1.27
46 Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol 2004 1.26
47 Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal 2013 1.26
48 Career development of physician scientists: a survey of leaders in academic medicine. Am J Med 2011 1.26
49 Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am J Physiol Cell Physiol 2004 1.26
50 Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension 2010 1.24
51 Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions. Mol Cell Biol 2003 1.23
52 Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler Thromb Vasc Biol 2005 1.22
53 NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor. Free Radic Biol Med 2010 1.18
54 Dual regulation of cofilin activity by LIM kinase and Slingshot-1L phosphatase controls platelet-derived growth factor-induced migration of human aortic smooth muscle cells. Circ Res 2007 1.17
55 C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 2004 1.12
56 Stimulation of cellular signaling and G protein subunit dissociation by G protein betagamma subunit-binding peptides. J Biol Chem 2003 1.12
57 Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products. Free Radic Biol Med 2007 1.10
58 Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species. J Biol Chem 2003 1.08
59 Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 2002 1.07
60 Redox control of vascular smooth muscle migration. Antioxid Redox Signal 2010 1.06
61 Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxid Redox Signal 2002 1.06
62 Detection of reactive oxygen species and nitric oxide in vascular cells and tissues: comparison of sensitivity and specificity. Methods Mol Med 2007 1.03
63 NADPH oxidases: new regulators of old functions. Antioxid Redox Signal 2006 1.01
64 Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species. Atherosclerosis 2007 0.99
65 Oxidative stress and diabetic vascular complications. Curr Diab Rep 2004 0.96
66 Differential roles of NADPH oxidases in vascular physiology and pathophysiology. Front Biosci (Schol Ed) 2012 0.95
67 NADPH oxidases: molecular understanding finally reaching the clinical level? Antioxid Redox Signal 2009 0.93
68 Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2. Mol Pharmacol 2005 0.91
69 Functional evaluation of nonphagocytic NAD(P)H oxidases. Methods Enzymol 2002 0.91
70 Platelet-derived growth factor (PDGF) regulates Slingshot phosphatase activity via Nox1-dependent auto-dephosphorylation of serine 834 in vascular smooth muscle cells. J Biol Chem 2011 0.88
71 The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease. Antioxid Redox Signal 2002 0.88
72 Polymerase delta interacting protein 2 sustains vascular structure and function. Arterioscler Thromb Vasc Biol 2013 0.87
73 Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2009 0.87
74 Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9. J Vasc Res 2012 0.87
75 Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol Pharmacol 2003 0.85
76 Reactive oxygen species sensitivity of angiotensin II-dependent translation initiation in vascular smooth muscle cells. J Biol Chem 2003 0.84
77 Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation. PLoS One 2013 0.83
78 Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor. Exp Cell Res 2011 0.83
79 Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association. Circ Res 2016 0.83
80 Hydrogen peroxide regulates osteopontin expression through activation of transcriptional and translational pathways. J Biol Chem 2013 0.81
81 Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK. Am J Physiol Cell Physiol 2011 0.81
82 NADPH oxidases: progress and opportunities. Antioxid Redox Signal 2014 0.81
83 The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. Am J Physiol Heart Circ Physiol 2013 0.79
84 Nox is playing with a full deck in vascular smooth muscle, a commentary on "Noxa1 is a central component of the smooth muscle NADPH oxidase in mice". Free Radic Biol Med 2006 0.79
85 The yin/yang of superoxide dismutase mimetics: potential cardiovascular therapies? Br J Pharmacol 2003 0.77
86 Out phoxing the endothelium: what's left without p47? Circ Res 2002 0.77
87 Mycophenolic acid is a new Nox2 inhibitor. Hypertension 2006 0.77
88 Redox control of growth factor signaling in heart, lung, and circulation. Antioxid Redox Signal 2003 0.76
89 Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift. Circ Res 2014 0.75
90 Notice of retraction. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:489-95. Arterioscler Thromb Vasc Biol 2013 0.75
91 Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association. Circ Res 2017 0.75
92 Polymerase δ-interacting Protein 2: A Multifunctional Protein. J Cardiovasc Pharmacol 2017 0.75